Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer CandidateSeeking Alpha • 03/31/24
Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerBusiness Wire • 03/28/24
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsBusiness Wire • 03/14/24
Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should KnowZacks Investment Research • 03/08/24
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateBusiness Wire • 02/29/24
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of DirectorsBusiness Wire • 01/08/24
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid TumorsBusiness Wire • 01/08/24
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 11/02/23
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 08/03/23
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory BoardBusiness Wire • 06/01/23
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business UpdateBusiness Wire • 05/04/23
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateBusiness Wire • 03/15/23
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 11/03/22
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business UpdateBusiness Wire • 08/04/22
Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development ProgramBusiness Wire • 08/01/22
Nuvation Bio Inc. (NUVB) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/27/22
Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory OfficerBusiness Wire • 07/18/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nuvation Bio Inc. - NUVBPRNewsWire • 07/14/22
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Nuvation Bio Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 07/01/22